Why Option Care Health, Inc.’s (OPCH) Stock Is Up 32.91%
As of Tuesday, October 06, Option Care Health, Inc.’s OPCH share price has surged by 32.91%, which has investors questioning if this is right time to sell.Michael Rose
Stock Evaluator: Option Care Health, Inc. (OPCH)
Option Care Health, Inc. OPCH
$31.11
0.04
0.12%
October 12, 2026 3:16:21 PM
EST
Volume: 2,297,688
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failure; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer’s disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. The company is headquartered in Bannockburn, Illinois.
Commentary & Analysis
Why Option Care Health, Inc.’s (OPCH) Stock Is Up 32.97%
As of Tuesday, October 06, Option Care Health, Inc.’s OPCH share price has surged by 32.97%, which has investors questioning if this is right time to sell.Tudor Pop
3 Undervalued Health Care Providers & Services Stocks for Monday, October 05
Discover the top 3 undervalued Health Care Providers & Services stocks for Monday, October 05 based on AAII’s Stock Grades.Jenna Brashear
5 Undervalued Health Care Providers & Services Stocks for Thursday, August 27
Discover the top 5 undervalued Health Care Providers & Services stocks for Thursday, August 27 based on AAII’s Stock Grades.Michael Rose
Which Is a Better Investment, NeoGenomics, Inc. or Option Care Health, Inc. Stock?
Learn more about whether NeoGenomics, Inc. or Option Care Health, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.Tudor Pop
Financial Summary
| Share Statistics | OPCH | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $4,653.8 | $1,631.5 | 67% |
|
| Shares Out (Mil) | 153.5 | 77.7 | 71% |
|
| Institutional Ownership | 97.2% | 87.7% | 73% |
|
| Float (Mil) | 147.7 | 55.9 | 68% |
|
| Beta | 0.61 | 0.81 | 36% |
|
| Avg Daily Volume (000s) | 11,111 | 539 | 97% |
|
| Price Change (52-week) |
14.3% | 78.8% | 65% |
|
| Growth | OPCH | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 13.3% | 10.6% | 69% |
|
| Net Income (5yr) | 94.2% | (0.3%) | 98% |
|
| EPS (5yr) | 97.7% | 3.0% | 99 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (52.2%) | (17.3%) | 6% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 11 | 11 | 11 | |
| Current EPS | $0.487 | $1.882 | $2.083 | |
| Month Ago EPS | $0.487 | $1.882 | $2.082 | |
| # Rev Up | 0 | 1 | 1 | |
| # Rev Down | 2 | 1 | 0 | |
| Three Months Ago EPS | $0.482 | $1.841 | $2.050 | |
| Year/Year Chg | 39.1% | 48.2% | 82.3% | |
| Financials | OPCH | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $5,694 | $1,505 | 76% |
|
| Net Income (TTM) (Mil) | $210 | $26 | 68% |
|
| EPS (TTM) | $1.332 | $0.200 | 65% |
|
| Operating Cash Flow (TTM) (Mil) | $347 | $157 | 66% |
|
| Net Cash Flow (TTM) (Mil) | ($5) | $2 | 34% |
|
| Long-Term Debt (Q1) (Mil) | $1,238 | $374 | 68% |
|
| Enterprise Value (Q1) (Mil) | $4,711 | $2,284 | 62% |
|
| Valuation | OPCH | Industry Median |
Percentile (All Stocks) |
|
| P/B | 3.69 | 2.93 | 72% |
|
| P/E | 23.5 | 25.2 | 61% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | 0.2 | 1.1 | 10% |
|
| Ratios | OPCH | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 19.1% | 27.6% | 20% |
|
| Net Margin | 3.7% | 1.2% | 43% |
|
| ROA | 6.2% | 2.1% | 76% |
|
| ROE | 16.0% | 6.9% | 73% |
|
| Liabilities to Assets | 62.7% | 60.8% | 57% |
|
| F-Score | 5 | 5 | 50% |
|
Passing Stock Screens
As of 10/9/2026, from a list of 60 stock screening strategies,
GURU STRATEGY
Kirkpatrick Bargain Screen
Factors: Value, Momentum
Investing model outlined in Charles Kirkpatrick's book, Beat the Market: Invest by Knowing What Stocks to Buy and What Stocks to Sell.
| Performance Since Inception: | 6.8% |
| +/- S&P 500: | -0.7 |
